6vonder Maase H, Hansen SW, Roberts JT, et al. Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase Ⅲ study. J Clin Oncol, 2000, 18: 3068-3077.
7yon der Maase H, Sengelov L, Roberts JT, et al. Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer. J Clin Oncol, 2005, 23: 4602-4608.
8Advanced Bladder Cancer (ABC) Meta-analysis Collaboration.Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta analysis of individual patient data advanced bladder cancer. Eur Urol, 2005, 48: 202-205.
9Winquist E, Kirchner TS, Segal R, et al, Genitourinary Cancer Disease Site Group, Cancer Care Ontario Program in Evidence-based Care Practice Guidelines Initiative. Neoadjuvant chemotherapy for transitional cell carcinoma of the blad der: a systematic review and recta-analysis. J Urol, 2004, 171 :561-569.
10Grossman HB, Natale RB, Tangen CM, et al. Neoadjuvant chemotherapy plus cystectomy compared with cysteetorny alone for locally advanced bladder cancer. N Engl J Med, 2003, 349: 859-866.
